Nurix Therapeutics, Inc.NRIXNASDAQ
LOADING
|||
| Metric | Nov 21 | Nov 22 | Nov 23 | Nov 24 | Nov 25 |
|---|---|---|---|---|---|
| Revenue | 30 | 39↑29.8% | 77↑99.3% | 55↓29.1% | 84↑54.0% |
| Gross Profit | -87 | -146↓68.3% | -112↑23.1% | -167↓49.0% | 65↑139.0% |
| Operating Income | -118 | -184↓56.0% | -155↑15.7% | -213↓37.4% | -286↓34.1% |
| Net Income | -117 | -180↓53.9% | -144↑20.2% | -194↓34.5% | -264↓36.6% |
| EBITDA | -116 | -180↓55.1% | -149↑17.1% | -205↓37.7% | -245↓19.4% |
| EPS Diluted | -2.73 | -3.71↓35.9% | -2.65↑28.6% | -2.88↓8.7% | -3.05↓5.9% |